The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Feasibility of an explainable AI-based therapeutic recommendation-tool utilizing tumor gene expression profiles in advanced and refractory solid tumors.
 
Ouissam Al Jarroudi
Honoraria - Omicure
Research Funding - Omicure (Inst)
 
Coralie Williams
Employment - Ariana Pharma
 
Rita Santos
Employment - OmiCure
Stock and Other Ownership Interests - AstraZeneca; GlaxoSmithKline
 
Armelle Dufresne
No Relationships to Disclose
 
Valéry Attignon
No Relationships to Disclose
 
Anthony Ferrari
No Relationships to Disclose
 
Sandrine Boyault
No Relationships to Disclose
 
Laurie Tonon
No Relationships to Disclose
 
Séverine Tabone-Eglinger
No Relationships to Disclose
 
Philippe Alexandre Cassier
Honoraria - Amgen; ITeos Therapeutics; Janssen
Consulting or Advisory Role - OSE Immunotherapeutics
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Bayer (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Innate Pharma (Inst); Janssen (Inst); Lilly (Inst); Loxo (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Plexxikon (Inst); Roche/Genentech (Inst); Taiho Pharmaceutical (Inst); Toray Industries (Inst); Transgene (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca/MedImmune; Merck Serono; Merck Sharp & Dohme; Netris Pharma; Roche
 
Nadège Corradini
No Relationships to Disclose
 
Armelle Vinceneux
Travel, Accommodations, Expenses - Astellas Pharma; Pfizer
 
Aurélie Swalduz
Honoraria - Amgen; AZD; Boehringer Ingelheim; Roche
Consulting or Advisory Role - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb/Medarex; Janssen; Roche
Travel, Accommodations, Expenses - Boehringer Ingelheim; Janssen
 
Alain Viari
No Relationships to Disclose
 
Sylvie Chabaud
No Relationships to Disclose
 
David Pérol
Honoraria - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol Myers Squibb Foundation; Ipsen; Lilly; Merck Sharp & Dohme; Novartis; Roche; Takeda
 
Mohammad Afshar
Leadership - Ariana Pharma
Stock and Other Ownership Interests - Ariana Pharma; Omicure
Research Funding - Anavex Life Sciences (Inst); Sanofi (Inst)
 
Jean-Yves Blay
Leadership - Innate Pharma
Honoraria - AstraZeneca; Bayer; BMS; Deciphera; Ignyta; MSD; PharmaMar; Roche
Consulting or Advisory Role - Bayer; Blueprint Medicines; Deciphera; Deciphera; Deciphera; Deciphera; Karyopharm Therapeutics; Pharmamar; Roche
Research Funding - AstraZeneca (Inst); Bayer (Inst); BMS (Inst); DEciphera (Inst); GlaxoSmithKline (Inst); MSD (Inst); Novartis (Inst); OSE Pharma (Inst); Pharmamar (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Roche
 
Olivier Tredan
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo Europe GmbH; Eisai Europe; Gilead Sciences; Lilly; MSD Oncology; Pfizer; Pierre Fabre; Pierre Fabre; Roche; Sandoz-Novartis; Seagen
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); MSD Oncology (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Lilly; MSD Oncology; Novartis; Pfizer; Roche
 
Pierre Saintigny
Honoraria - Archer; Bristol Myer Squibb; HTG Molecular Diagnostics; Inivata; Roche Molecular Diagnostics
Research Funding - AstraZeneca; BMS Foundation; Novartis; Omicure (Inst); Roche
Travel, Accommodations, Expenses - AstraZeneca; Bristol Myer Squibb; Illumina; Roche